Safety assessments
Cancer
ADVERSE EVENTS, CANCER
During hospitalization, patients underwent daily physical and neurologic exams (including vital signs), hematology, blood chemistry, and urine tests, registration of adverse events (AEs) and concomitant medication use. This was repeated at 4, 8, 12, 24, 36, and 52 weeks post-discharge. AE severity was graded according to the NCI Common Terminology Criteria (CTC) for AEs, version 4.0, and the European Organization for the Research and Treatment of Cancer Quality of Life (QOL) Questionnaire (EORTC QLQ-30) [